Atherosclerosis Or Coronary Artery Disease (CAD) – Drug Pipeline Analysis and Market Forecasts to 2016
The coronary artery disease (CAD) market is a highly competitive market and is expected to become more competitive until 2016. Three major patent expiries are expected during the forecast period, Plavix and Lipitor by 2011 and Crestor by 2016. The patient expiries of these blockbuster drugs will
Atherosclerosis Or Coronary Artery Disease (CAD) – Drug Pipeline Analysis and Market Forecasts to 2016
The coronary artery disease (CAD) market is a highly competitive market and is expected to become more competitive until 2016. Three major patent expiries are expected during the forecast period, Plavix and Lipitor by 2011 and Crestor by 2016. The patient expiries of these blockbuster drugs will
Atherosclerosis Or Coronary Artery Disease (CAD) – Drug Pipeline Analysis and Market Forecasts to 2016
The CAD market is currently very competitive and is expected to get more competitive in the future. The market is expected to witness a decline between 2011 and 2013 due to the patent expiries of a few blockbuster drugs used in the treatment of CAD. The major drug patent expiries expected in the